Chime Biologics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
900
- Latest Deal Type
-
Series B1
- Investors
-
4
Chime Biologics General Information
Description
Developer and manufacturer of biological products designed to provide customers with a one-stop biopharmaceutical chemistry, manufacturing and controls (CMC) solution. The company offers omclude water injection, freeze drying and pre-filling medicine and supports early drug development to late clinical research and commercial cGMP production to meet the dynamic needs of the biopharmaceutical industry, thereby providing patients with affordable medicine options and improved level of treatment.
Contact Information
Website
www.chimebiologics.comCorporate Office
- Number 388, Gaoxin 2nd Road
- East Lake High-tech Development Zone
- Wuhan, Hubei 430000
- China
Corporate Office
- Number 388, Gaoxin 2nd Road
- East Lake High-tech Development Zone
- Wuhan, Hubei 430000
- China
Chime Biologics Timeline
Chime Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B1) | 16-Dec-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 01-Feb-2023 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A1) | 26-Mar-2021 | $190M | $315M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 10-Mar-2020 | $125M | $125M | Completed | Generating Revenue |
Chime Biologics Comparisons
Industry
Financing
Details
Chime Biologics Competitors (49)
One of Chime Biologics’s 49 competitors is Solvias, a Private Equity-Backed company based in Kaiseraugst, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Solvias | Private Equity-Backed | Kaiseraugst, Switzerland | ||||
| Bellen Chemistry | Venture Capital-Backed | Beijing, China | ||||
| Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA | ||||
| MabPlex | Venture Capital-Backed | Yantai, China | ||||
| JOINN Biologics | Venture Capital-Backed | Beijing, China |
Chime Biologics Signals
Chime Biologics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fidelity International | Asset Manager | Minority | ||
| Panacea Capital (California) | Venture Capital | Minority | ||
| VMS Group (Hong Kong) | Growth/Expansion | Minority | ||
| Biomark Capital | PE/Buyout | Minority |
Chime Biologics Investments (1)
Chime Biologics’s most recent deal was a Later Stage VC with Sumgen. The deal was made on 25-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sumgen | 25-Dec-2025 | Later Stage VC | Drug Discovery |
Chime Biologics FAQs
-
When was Chime Biologics founded?
Chime Biologics was founded in 2013.
-
Where is Chime Biologics headquartered?
Chime Biologics is headquartered in Wuhan, China.
-
What is the size of Chime Biologics?
Chime Biologics has 900 total employees.
-
What industry is Chime Biologics in?
Chime Biologics’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Chime Biologics a private or public company?
Chime Biologics is a Private company.
-
What is Chime Biologics’s current revenue?
The current revenue for Chime Biologics is .
-
How much funding has Chime Biologics raised over time?
Chime Biologics has raised $332M.
-
Who are Chime Biologics’s investors?
Fidelity International, Panacea Capital (California), VMS Group (Hong Kong), and Biomark Capital have invested in Chime Biologics.
-
Who are Chime Biologics’s competitors?
Solvias, Bellen Chemistry, Charles River Laboratories International, MabPlex, and JOINN Biologics are some of the 49 competitors of Chime Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process